Cyclobenzaprine: Uses, Dosage & Side Effects

Cyclobenzaprine Hydrochloride is a Muscle Relaxant (Tricyclic) used for Acute muscle spasms and pain. Learn about dosage, side effects, and important safety considerations.

11 min read

Quick Facts

Drug Class
Muscle Relaxant (Tricyclic)
Primary Indication
Acute muscle spasms and pain
Typical Starting Dose
5-10 mg three times daily; ER: 15 mg daily
Maximum Daily Dose
30 mg daily (immediate release); 15 mg daily (ER)

What Is Cyclobenzaprine Hydrochloride?

Cyclobenzaprine Hydrochloride is a Muscle Relaxant (Tricyclic) medication used to manage Acute muscle spasms and pain. This agent is available in both prescription and over-the-counter formulations depending on jurisdiction and indication. The medication has been extensively studied and has a well-established safety and efficacy profile when used appropriately. Healthcare providers often select this agent based on patient-specific factors including comorbidities, concurrent medications, and treatment goals.

Patients should understand that pain management is most effective when combined with non-pharmacological approaches including physical therapy, rest, and lifestyle modifications.

How Cyclobenzaprine Hydrochloride Works
Cyclobenzaprine Hydrochloride is a tricyclic muscle relaxant that reduces muscle spasms through central nervous system mechanisms. It is structurally similar to tricyclic antidepressants but is primarily used for acute musculoskeletal pain.

Indications

  • Acute muscle spasms and pain
  • Acute musculoskeletal pain
  • Chronic pain conditions
  • Inflammatory joint diseases
  • Headaches and migraines (select agents)
  • Dysmenorrhea
  • Post-operative pain management

Dosage and Administration

Immediate Release: 5-10 mg three times daily; ER: 15 mg daily

Maximum Daily Dose: 30 mg daily (immediate release); 15 mg daily (ER)

Duration: Follow prescribing guidelines and healthcare provider instructions. For over-the-counter use, do not exceed 10 days without consulting a healthcare provider.

Special Populations: Elderly patients and those with renal or hepatic impairment may require lower doses or longer dosing intervals. Consult prescribing information for specific guidance.

Clinical Note
Take with food or milk to minimize GI upset. Do not exceed recommended doses. Report signs of GI bleeding (dark stools, vomiting blood) or allergic reactions immediately. Continue only as long as clinically indicated. Use the lowest effective dose for the shortest duration possible.

Side Effects

Common: Nausea, dyspepsia, abdominal pain, headache, dizziness, drowsiness (muscle relaxants)

Serious but Rare: GI bleeding, perforation, acute kidney injury, cardiovascular events, liver dysfunction, anaphylaxis

Warning
Recommended for short-term use (2-3 weeks) only due to lack of long-term efficacy data and risk of dependence Sedation, dizziness, dry mouth common; risk of CNS depression with alcohol or other sedating drugs; anticholinergic effects possible

CARDIOVASCULAR RISK: This medication may increase the risk of heart attack and stroke, especially with long-term use and in patients with cardiovascular risk factors.

GI RISK: Risk of serious gastrointestinal complications including bleeding and perforation, especially in elderly patients, those with ulcer history, and concurrent corticosteroid or anticoagulant use.

RENAL RISK: May cause acute kidney injury, particularly in patients with existing renal impairment, volume depletion, or heart failure.

For muscle relaxants: Use for acute conditions only (typically 2-3 weeks). Do not drive or operate machinery until effects are known.

Contraindications

  • Acute MI
  • Congestive heart failure
  • Cardiac arrhythmias
  • Hypersensitivity to cyclobenzaprine
  • Concurrent MAOIs

Drug Interactions

  • CNS depressants (alcohol, benzodiazepines): enhanced sedation
  • Anticholinergic drugs: additive anticholinergic effects
  • SSRIs: potential serotonin syndrome
  • Tramadol: seizure risk
  • TCAs: additive effects

Key Clinical Evidence

Clinical evidence supports the use of Cyclobenzaprine Hydrochloride for acute and chronic pain management in appropriate patient populations. Current evidence-based guidelines recommend individualized treatment approaches considering patient comorbidities and risk factors.

Medically reviewed by

Medical Review Team, Pain Management

Last updated: 2026-02-17Sources: 2

The content on Medical Atlas is for informational purposes only. It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider.